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While Zika virus (ZIKV) is now widely recognized as a teratogen, the frequency and full
spectrum of adverse outcomes of congenital ZIKV infection remains incompletely
understood.
Methods
Participants in the MERG cohort of pregnant women with rash, recruited from the surveil-
lance system from December/2015-June/2017. Exposure definition was based on a combi-
nation of longitudinal data from molecular, serologic (IgM and IgG3) and plaque reduction
neutralization tests for ZIKV. Children were evaluated by a team of clinical specialists and
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by transfontanelle ultrasound and were classified as having microcephaly and/or other
signs/symptoms consistent with congenital Zika syndrome (CZS). Risks of adverse out-
comes were quantified according to the relative evidence of a ZIKV infection in pregnancy.
Findings
376 women had confirmed and suspected exposure to ZIKV. Among evaluable children
born to these mothers, 20% presented with an adverse outcome compatible with exposure
to ZIKV during pregnancy. The absolute risk of microcephaly was 2.9% (11/376), of calcifi-
cations and/or ventriculomegaly was 7.2% (13/180), of additional neurologic alterations was
5.3% (13/245), of ophthalmologic abnormalities was 7% (15/214), and of dysphagia was
1.8% (4/226). Less than 1% of the children experienced abnormalities across all of the
domains simultaneously. Interpretation: Although approximately one-fifth of children with
confirmed and suspected exposure to ZIKV in pregnancy presented with at least one abnor-
mality compatible with CZS, the manifestations presented more frequently in isolation than
in combination. Due to the rare nature of some outcomes and the possibility of later manifes-
tations, large scale individual participant data meta-analysis and the long-term evaluation of
children are imperative to identify the full spectrum of this syndrome and to plan actions to
reduce damages.
Author summary
The ability to meaningfully quantify the absolute and relative risks of Congenital Zika
Syndrome is contingent on the accurate identification of ZIKV infections in pregnant
women and the long-term follow-up of children at risk. This study builds on the evidence
base on ZIKV in pregnancy by not only examining pregnancy and birth outcomes, but
also considering later onset manifestations of Congenital Zika Syndrome, conducting a
deep and standardized investigation of infant outcomes. In addition, it used unprece-
dented repeated testing and the use of multiple diagnostic platforms, including qRT-PCR,
IgM and IgG3 ELISAs, and PRNTs to identify ZIKV cases. The absolute risk of micro-
cephaly was 2.9%, of calcifications and/or ventriculomegaly was 7.2%, of additional neu-
rologic alterations was 5.3%, of ophthalmologic abnormalities was 7% and of dysphagia
was 1.8%. The manifestations presented more frequently in isolation than in combination
(i.e., less than 1% of the children experienced abnormalities across all of the domains
simultaneously). Although approximately one-fifth of children with confirmed and sus-
pected exposure to ZIKV in pregnancy presented with at least one abnormality compati-
ble with CZS, the manifestations presented more frequently in isolation than in
combination
Introduction
Since the start of the microcephaly epidemic in the Americas in 2015, evidence detailing the
consequences of prenatal exposure to Zika virus (ZIKV) has been accumulating. Case reports
provided vital descriptions mainly of affected children with severe manifestations [1], and
shed light on both common features (e.g., calcifications [2]) as well as organ system-specific
signs and symptoms (e.g., cryptorchidism [3]). A constellation of structural birth defects and
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functional disabilities is now clinically recognizable as Congenital Zika Syndrome (CZS) [4,5],
though there are no standard criteria for diagnosing CZS. Key questions persist related to the
relative frequency of CZS and its overlapping clinical features.
To date, several cohort studies of ZIKV-infected pregnant women have begun to estimate
the risks of adverse pregnancy and birth outcomes after infection [6–13] and consistently esti-
mate the absolute risk of microcephaly to be approximately 5%. However, there is wide varia-
tion in the estimated frequencies of other adverse outcomes, ranging from 6 [7] to 46% [6].
These other outcomes mainly include grossly abnormal clinical or brain imaging findings or
both [6], often accompanied by neurologic and ocular defects [7]. As methodological issues
limit the comparability of the existing findings, the spectrum of abnormalities arising from
prenatal exposure to ZIKV and the risk of each of them—either separately or in combination
—remains incompletely understood.
Pernambuco in the northeast of Brazil was the epicenter of the microcephaly epidemic that,
along with a cluster of other neurological disorders, triggered the World Health Organization’s
declaration of a Public Health Emergency of International Concern[14]. At the request of the
Brazilian Ministry of Health and the State Health Secretariat, the Microcephaly Epidemic
Research Group (MERG) was assembled, bringing together multidisciplinary investigators
from several institutions across Pernambuco state and abroad. The MERG was tasked with
providing an initial description of microcephalic cases [1], verifying the association between
prenatal ZIKV exposure and microcephaly using a case-control study [15,16], and estimating
the risks of adverse outcomes using a cohort study of pregnant women.
The pregnancy cohort study, MERG cohort, was designed at the height of the epidemic in
coordination with the public health response efforts of the Pernambuco State Health Secretar-
iat. This study adopted a unique approach evaluating the children by different groups of spe-
cialists using standardized protocol and forms, on the same day, and quantifying the risks
according to the relative evidence for a ZIKV infection in pregnancy, contributing to under-
standing of the risks and spectrum of CZS. This comprehensive evaluation allowed us to inves-




The project was approved by the Research Ethics Committee of the Aggeu Magalhães / Fiocruz
Research Center, with CAAE: 53240816.4.0000.5190 and followed the ethical procedures rec-
ommended for this type of study by Resolution MS/CNS 466/2012. Free and informed written
consent was requested for all mothers/legal guardians of children.
Study design and data collection
Following the identification of the microcephaly epidemic, in December 2015, the Pernam-
buco State Health Department introduced a surveillance system for pregnant women present-
ing with rash (Center for Strategic Information on Health Surveillance in Pernambuco;
CIEVS/PE). Participants in the MERG cohort were recruited from Pernambuco state’s com-
pulsory notification system for pregnant women with rash. The surveillance protocols of the
Pernambuco State Health Secretariat and MERG protocols were harmonized, and some activi-
ties shared. Pregnant women with rash were notified to the surveillance program by the health
units, and blood samples collected within five days of rash onset (time point 1). At least 14
days after notification, the MERG fieldworkers recruited these women into this study, col-
lected a second blood sample and administered a standardized questionnaire (time point 2). In
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cases of livebirths, a third blood sample was collected from participating women after delivery
(time point 3). Testing at each timepoint was independent of the others (i.e., women could be
tested at one point even if they had not been tested in the previous one).
Recruitment commenced in December/2015 and included women residing up to 120km
from the Metropolitan Region of Recife. The first blood samples were sent to the Central Labo-
ratory of Public Health in Recife, where were separated and stored at -80˚C until further diag-
nostic testing was performed at the Laboratorio de Virologia e Terapia Experimental of the
Fundação Oswaldo Cruz (LAVITE-Fiocruz). The second and third blood samples were sepa-
rated, stored, and tested at LAVITE-Fiocruz.
At baseline, pregnant women were evaluated in terms of sociodemographic factors (age,
race/ethnicity, years of education, social class, and monthly per capita family income), reproduc-
tive history (previous pregnancy, children with malformations from previous pregnancies), cur-
rent pregnancy characteristics (smoking, illicit drug use, delivery mode). For social class we used
the new Brazilian Economic Classification Criteria [17], which is based on the pattern of con-
sumption of the Brazilian families. It ranges from A (higher) to E (lower). Smoking and illicit
drug use were defined according to the information given by the pregnant women in response
to the questionnaire, independently of the gestational age and of the frequency and quantity.
Gestational age at the time of rash onset and delivery was estimated, in order of priority, by
first trimester ultrasound, the date of last menstrual period, and any other trimester
ultrasound.
Diagnostic assays
The main exposure, prenatal ZIKV infection, was based on clinical (rash in any form), and lab-
oratory criteria, based on the combination of longitudinal data from nucleic acid amplification
tests, serologic assays and plaque reduction neutralization tests, as previously described [18].
Further laboratory tests were performed in the pregnant women with rash to test for TORCH
agents and other arboviruses.
Molecular assay. Maternal sera were tested for the detection of ZIKV RNA by one-step
qRT-PCR using primers and probes previously described [19].
Serologic assays. Samples were screened for the detection of ZIKV-specific IgM antibod-
ies by capture-IgM enzyme-linked immunosorbent assay (ELISA) [20]. Maternal sera were
also tested for the detection of ZIKV-specific IgG3 anti-non-structural protein 1 (NS1) anti-
bodies using a novel in-house ELISA following a protocol previously described [21]. ZIKV-
specific neutralizing activity was assessed in all available maternal sera by PRNT, following a
standardized protocol [22] carried out in Vero cells using a virus strain isolated in the study
setting: ZIKV (strain Brazil/PE243/2015) [23]. The cut-off value for PRNT positivity was
defined based on a 50% reduction in plaque counts (PRNT50). ZIKV-specific neutralizing
antibody titers were estimated by four-parameter nonlinear regression using the sigmoidal
dose response (variable slope) equation on GraphPad Prism 7.0a. Maternal sera were consid-
ered ZIKV-non-negative with PRNT50 titers�20, equivocal with PRNT50 titers�20 and
<100, and ZIKV-positive with PRNT50 titers�100. Seroconversion was considered to occur
with four-fold rises in PRNT50 titers or with a switch from negative (i.e.,<20) to non-negative
status (i.e.,�20). Maternal sera of a subsample was tested for DENV using Panbio Dengue IgG
Indirect ELISA.
Degrees of evidence of ZIKV infection
We categorized maternal ZIKV exposure according to the degree of evidence of infection (See
Ximenes et al. 2019 [18] for detailed description). Pregnant women were classified as Positive
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for ZIKV infection, Suspected or Negative. The positive group was divided into three subcate-
gories (robust, moderate and limited evidence) according to the level of diagnostic evidence.
Robust evidence was defined by a positive qRT-PCR, seroconversion, or at least two positive
serologic tests in pregnancy or by one positive IgM or IgG3 in pregnancy paired with a non-
negative PRNT50 within six months post-pregnancy. Moderate evidence was defined by one
positive IgM or IgG3 in pregnancy, an indication of seroconversion by PRNT50 during preg-
nancy (i.e., either a PRNT50 titer�1000 in pregnancy paired with a rise within 2 months post-
pregnancy or 4-fold rise in PRNT50 titer from pregnancy to within 2 months post-pregnancy),
or an equivocal PRNT50 test result in pregnancy paired with a positive PRNT50 within three
months post-pregnancy. Limited evidence of ZIKV infection was defined by a positive
PRNT50 in pregnancy or within 6 months post-pregnancy or an indication of PRNT50 sero-
conversion during the 2 to 3 months post-pregnancy. The Suspected ZIKV infection group
included two subcategories (limited evidence of flavivirus and inconclusive results). Limited
evidence of a flavivirus before or during pregnancy was defined by a PRNT50 titer between 20
and 100 or a non-negative result (i.e., unspecified titer�20) in pregnancy or within 1 month
post-pregnancy, providing evidence of infection by an unspecified flavivirus. The inconclusive
subgroup included pregnant women who tested IgM negative for ZIKV, but were tested more
than three months after the rash started, and women who showed inconsistency in the results
of the same test. We considered there to be evidence against ZIKV infection if all tests per-
formed in pregnancy were negative.
Pediatric assessment
All children born to the mothers of the MERG Pregnant Women Cohort were referred to just
one health unit where they were evaluated by different specialists of the MERG team, using
standardized protocols especially created for these assessments. Transfontanelle ultrasound
(TF-US) was performed within the first six months of life. Priority was given to those children
born to mothers with lab evidence of ZIKV infection, independently of the level of evidence,
but the evaluation was carried out for all children independently of suspicious of an abnormal-
ity. The timing of evaluation was constrained by the operational capacity of the research team,
as the Northeast of Brazil was the place where the cases of microcephaly were first identified
and Pernambuco was in the epicentre of the epidemic, and the study was designed and con-
ducted when the epidemic was already occurring. This evaluation of the outcomes of the preg-
nant women cohort was also the baseline evaluation of the MERG Paediatric Cohort.
Pediatricians evaluated infants for malformations or other abnormalities. Microcephaly
was defined as a head circumference falling two or more standard deviations below the mean
for age and sex. For infants born with gestational age�37 weeks, head circumference was eval-
uated using the WHO Anthro software and classified according to the World Health Organi-
zation (2007) growth charts [24]. For premature infants, age was corrected for gestational age
at delivery and classified using the Intergrowth (2015) growth charts [25]. Cases were classified
as having disproportionate microcephaly based on the ratio of head circumference to length
[2]. Where head circumference in cm was less than ½ length in cm –7 (1/2L-7), microcephaly
cases were considered to be disproportionate.
Pediatric neurologists examined children for: seizures, altered consciousness/behavior,
localized motor deficits, altered tonus or trophism, and pyramidal signs. Neuroimaging results
from the TF-US were assessed for: calcifications, cerebellar hypoplasia or atrophy, agenesis or
dysgenesis of the corpus callosum and diffuse cortical atrophy.
Otolaryngologists performed clinical and auditory evaluations, including the short latency
auditory brainstem response to stimuli. If the first screening test was abnormal, the test was
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repeated later. If the second test also indicated hearing loss, the child was referred for further
diagnosis.
Speech therapists evaluated infants’ ability to swallow and the stomatognathic system, fol-
lowing a clinical protocol based on the Pediatric Dysphagia Assessment Protocol [26].
Pediatric ophthalmologists and retina specialists from the Altino Ventura Foundation, eval-
uated children for: visual acuity testing, oculomotility testing, cycloplegic refraction, indirect
ophthalmoscopy, and wide-angle fundus imaging (Retcam Shuttle, Clarity Medical Systems,
Pleasanton, California, United States of America).
Children were classified as having signs and symptoms consistent with CZS if they had one
or more of the following: microcephaly, neuroimaging, neurologic, auditory and ophthalmo-
logic abnormalities.
Statistical analysis
We estimated the absolute risk and respective 95% confidence interval of microcephaly and
other adverse outcomes potentially related to prenatal exposure to Zika virus infection sepa-
rately for each outcome and for the combined presentation. The analysis was stratified accord-
ing to the level of laboratory evidence, allowing a sensitivity analyses. We also estimated the
relative risk, 95% confidence interval and p-value (Chi-squared test) for the association
between trimester of gestation in which the infection occurred, years of education and social
class with microcephaly and with any of the other abnormalities. For comparing the clinical
features of ZIKV infection we used the Chi-squared test or Fisher’s exact tests for categorical
variables and the Mann-Whitney U tests for continuous variables. We used the Stata software
(version 14.1 (College Station, Texas, USA)) for the statistical analyses.
Results
A total of 694 pregnant women with rash was recruited between December/2015 and June/
2017. Out of the total, 364 (52.4%) women were tested for ZIKV infection after delivery (at
time point 3), 240 (34.6%) at 14 or more days after notification (at time point 2) and 90
(13.0%) within five days of rash onset (at time point 1). A total of 503 children born to these
women were evaluated sometime after birth (Fig 1). In relation to the exposure status of their
mothers, 277 were classified as having some level of laboratory evidence of ZIKV infection
during pregnancy, 78 of unspecified Flavivirus and for 19 the results were inconclusive. For
127 there was no laboratory evidence of ZIKV infection (Table 1).
The time elapsed between birth and first evaluation had a median of 4.65 months (IQR:
2.9–13.4). There were two foetal deaths, one with a gestational age of approximately 5 months
and the other with a gestational age of 34 weeks. Five deaths occurred after delivery, two within
one day, one within two months and two after a year. The two latter deaths occurred in chil-
dren with Down Syndrome. For three of these five children, including those with Down Syn-
drome, there was a report of severe cardiac malformation.
The sociodemographic characteristics, reproductive history and substance use of the preg-
nant women are presented in Table 1 and S1 Table.
Rash was referred in the interview by 98% of the women. Approximately 80% informed
having had fever, joint pain and fatigue/feebleness. Joint pain, joint swelling and presence of
secretion in the eyes when wake up were more frequent among women who had laboratory
evidence of ZIKV infection (Table 2).
Table 3 shows the absolute risk of the main adverse outcomes according to the level of
ZIKV exposure during pregnancy. The columns in bold summarise the information for all
positive categories (i.e., robust, moderate, and limited evidence) and the combined positive
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plus suspected categories (i.e., robust, moderate, and limited evidence plus flavivirus and incon-
clusive). In addition to absolute risks at first evaluation, we also added prospective information
of the risk of presenting with neurologic and ophthalmologic abnormalities and dysphagia at
any time during the follow up. Of the 503 pregnant women with rash, 12 cases of microcephaly
were identified, one occurring in a child born to a woman with no laboratory evidence of Zika
virus infection. Among the 376 women who were ZIKV positive or had suspected ZIKV expo-
sure, the absolute risk of microcephaly was approximately 3% (Table 3). Among these cases,
three were disproportionate. Nine had a TF-US performed and no abnormality was observed in
7; in one child cranial haemorrhage grade I was observed and in another, born to the woman
with no laboratory evidence of ZIKV infection, alteration of the optic nerve and retina, a benign
lump of the subaracnoid space and asymmetry were described. For two children (out of three)
with disproportionate microcephaly and TF-US performed, no abnormality was found.
Of 263/503 children who had TF-US performed, 30 had some imaging alteration, of which
21 were among non-negative. The absolute risk of any imaging alteration in children born to
non-negative mothers was 9.2% and of calcifications or ventriculomegaly 5.7%, but these risks
were similar among the offspring of negative mothers. Of the five children who had imaging
alteration and were born to ZIKV negative mothers, two were born to Chikungunya positive
mothers, one being PCR positive and, the other being IgM positive; two were born to mothers
negative for TORCH, Dengue and Chikungunya and one to a mother who was not tested for
TORCH.
Fig 1. Flow diagram of the MERG Pregnancy Cohort in Pernambuco, Brazil (2015–2017).
https://doi.org/10.1371/journal.pntd.0009216.g001
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Table 1. Characteristics of women with rash in the MERG Pregnancy Cohort in Pernambuco, Brazil (2015–2017).
Variables Totala N (%)
Sociodemographic factors
Age, years, Median (IQR) 501 26.2 (21–31)
Race/ethnicity 500
“Preto” (ie, black) 50 (10.0)
“Pardo” (ie, mixed race) 335 (67.0)
“Branco” (ie, white) 107 (21.4)
Other 8 (1.6)





A, B1, and B2 47 (9.4)
C1 90 (18.0)
C2 186 (37.1)
D and E 178 (35.5)




















ZIKV diagnosis in pregnancy 501
ZIKV-positive 277 (55.3)
Robust evidence, PCR 108
Robust evidence, serology 53
Moderate evidence, serology 53
Limited evidence, serology 53
Unspecified flavivirus-positive 78 (15.6)
Inconclusive 19 (3.8)
ZIKV-negative 127 (25.3)
aNumbers varied because of missing values.
bBased on the pattern of consumption of the Brazilian families, A being the higher and E being the lower.
cNot applicable due to abortion, stillbirth, or no previous pregnancy.
https://doi.org/10.1371/journal.pntd.0009216.t001
PLOS NEGLECTED TROPICAL DISEASES Zika related adverse outcomes in a cohort of pregnant women with rash
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009216 March 8, 2021 8 / 20
Microcephaly and TF-US suggestive of CZS occurred independently of the trimester in
which there was a probable Zika infection (Table 4).
A total of 14 children out of 277 had neurological alterations; 10 were born to women posi-
tive to ZIKV infection, 2 born to a woman who had unspecified flavivirus infection, one born
to a woman with inconclusive results and one whose mother did not have laboratory evidence
of ZIKV infection (Table 3). The later presented convulsions. Among those 10 born to women
positive to ZIKV infection, 7 children had only neurological alterations; two children had
Table 2. Clinical presentation of women with rash at the time of notification by ZIKV diagnostic status in the MERG Pregnancy Cohort in Pernambuco, Brazil
(2015–2017)a.







+ Limited (n = 277)
Unspecified flavivirus-




Rash 273 (98.6) 78 (100) 17 (84.2) 123 (96.8) 0.27 0.48
Location where rash
first appeared
Head/neck 19 (6.9) 6 (7.7) 0 (0) 4 (3.1) 0.17 0.19
Torso/back 46 (16.6) 12 (15.4) 1 (5.3) 27 (21.3) 0.26 0.16
Abdomen 127 (45.8) 38 (48.7) 9 (47.4) 53 (41.7) 0.44 0.35
Arms 60 (21.7) 18 (23.1) 9 (47.4) 29 (22.8) 0.79 0.92
Legs 43 (15.5) 10 (12.8) 1 (5.3) 16 (12.6) 0.44 0.60
Full body 18 (6.5) 7 (9.0) 0 (0) 7 (5.5) 0.70 0.64
Duration of rash, days
(Median (IQR))
4.5 (3–7) 4 (3–7) 5 (2–15) 5 (3–7) 0.29 0.23
Fever 220 (80.6) 64 (82.0) 11 (68.7) 97 (78.9) 0.69 0.71
Myalgia 197 (71.1) 47 (60.3) 10 (52.6) 82 (64.6) 0.19 0.49
Arthralgia 236 (85.2) 65 (83.3) 12 (63.2) 96 (75.6) 0.02 0.04
Joint swelling 196 (70.8) 51 (65.4) 9 (47.4) 76 (59.8) 0.03 0.08
Retro-bulbar pain 78 (28.2) 18 (23.1) 6 (31.6) 39 (30.7) 0.60 0.46
Secretions in the eyes
when waking up
20 (7.2) 5 (6.4) 0 (0) 3 (2.4) 0.06 0.07
Conjunctivitis 75 (27.1) 16 (20.5) 4 (21.0) 38 (29.9) 0.55 0.32
Photophobia 71 (25.6) 15 (29.2) 5 (26.3) 43 (33.9) 0.09 0.04
Headache 215 (77.6) 62 (79.5) 14 (73.7) 91 (71.6) 0.19 0.16
Vomiting/nausea 117 (42.2) 34 (43.6) 7 (36.8) 52 (40.9) 0.81 0.80
Rhinorrhea 37 (13.4) 10 (12.8) 2 (10.5) 10 (7.9) 0.11 0.11
Pruritis 232 (83.8) 63 (80.8) 13 (68.4) 108 (85.0) 0.74 0.49
Back pain 181 (65.3) 48 (61.5) 8 (42.1) 78 (61.4) 0.44 0.69
Fatigue 219 (79.1) 62 (79.5) 13 (68.4) 100 (78.7) 0.94 0.97
Pharyngitis 34 (12.3) 10 (12.8) 2 (10.5) 10 (7.9) 0.19 0.17
Cough 29 (10.5) 7 (9.0) 2 (10.5) 10 (7.9) 0.41 0.45
Abdominal pain 77 (27.8) 17 (21.8) 6 (31.6) 31 (24.4) 0.47 0.61
aThe numbers varied because of the missing values.
bComparison of the ZIKV-positive group versus the ZIKV-negative group: P values for categorical variables are from Chi-squared tests or, for variables with cells
including�5 observations, Fisher’s exact tests; P values for continuous variables are from Mann-Whitney U tests.
cComparison of the positive and suspected exposure group (i.e., ZIKV-positive, unspecified flavivirus positive, and inconclusive groups) versus the ZIKV-negative
group: P values for categorical variables are from Chi-squared tests or, for variables with cells including�5 observations, Fisher’s exact tests; P values for continuous
variables are from Mann-Whitney U tests.
https://doi.org/10.1371/journal.pntd.0009216.t002
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neurologic alterations and microcephaly (one with alteration of the optic nerve and orthopaedic
alterations). Alteration of the optic nerve was also observed in one child with no microcephaly.
The absolute risk of neurologic alterations among children born to women positive to
ZIKV infection was 4.6% (CI-95%: 2.5–8.4%) (Table 3). Taking the alterations separately the
risk of altered level of consciousness/behaviour, localized motor deficit, convulsion, inade-
quate visual response and sign of pyramidal release was less than 2%, while the risk of tonus
alteration was slightly higher (3.5%, CI-95%: 1.6–7.6%).




















































































At any time - - - - 28/216 (13.0)
9.1–18.2































At any time - - - - 14/187 (7.5)
4.5–12.3






















0/7 (0) 11/223 (4.9)
2.7–8.7
0/30 (0) 0.367 0.371
At any time - - - - 10/199 (5.0)
2.7–9.1
- - 11/223 (4.9)
2.7–8.7












0/17 (0) 0/9 (0) 4/226 (1.8)
0.7–4.7
0/30 (0) 1.000 1.000
At any time - - - - 6/200 (3.0)
1.3–6.6
- - 6/226 (2.6)
1.2–5.8
0/30 (0) 0.856 0.939
aCalcification or ventriculomegaly.
bAt least one of the following: inappropriate visual response, alteration of tonus or trophism, altered level of consciousness/behavior and convulsions.
cThe denominator varies according to the missing values for each outcome.
DNine children repeated the test and it was normal on the second evaluation.
https://doi.org/10.1371/journal.pntd.0009216.t003
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A total of 15 out 214 children born to non-negative mothers had ophthalmologic alterations
compatible with ZIKV infection, corresponding to an absolute risk of 7% (CI-95%: 4.2% to
11.3%) (Table 3). Taking each of the alterations separately, the risk ranged from 1% (strabis-
mus, nystagmus) to 4.2% (optic nerve).
The absolute risk of dysphagia among children born to women positive to ZIKV infection
was around 2% (Table 3). One of these children had microcephaly, neurologic, ophthalmologic
alterations and imaging abnormalities (identified in the TF-US, computed tomography and
magnetic resonance). Another had neurologic and ophthalmologic alterations. In the two oth-
ers no other alterations were detected.
A total of 253 children undergone a hearing screening evaluation and 11 failed, none of the
later were born to ZIKV negative mothers. However, nine of these children were retested and
they all passed in the second evaluation.
There was no statistically significant difference in the risk of adverse outcomes between
children born to mothers positive or with suspected Zika exposure and children born to nega-
tive mothers.
The percentage of children that had at least one of the abnormalities compatible with CZS
was around 20% (Table 5), considering either children born to mothers who were positive, or
non-negative (adding mothers with unspecified flavivirus or inconclusive results). The inter-
section between these different abnormalities did not exceed 1%.
Approximately two-thirds of the pregnant women notified with rash belonged to the lower
social classes and only a small proportion had higher education (Table 1). There was no associ-
ation between Zika related adverse outcomes and socioeconomic conditions (S2 Table).
Infection by other arbovirus or TORCH during pregnancy by ZIKV diagnostic status are
presented in S3 Table. The frequency of TORCH was below 1%. Approximately 10% tested
IgM positive for Dengue and 30% for Chikungunya.
Discussion
The absolute risk of occurrence of microcephaly in children born to non-negative mothers
(positive and suspected) was approximately 3%. Most of the children with microcephaly who
had a TF-US performed had no brain abnormality detected. The risk of calcifications and/or
ventriculomegaly was 5.7%, of neurologic alterations was 4.6%, of ophthalmologic abnormali-
ties was 6.3% and of dysphagia was around 2%. The percentage of children that had at least
Table 4. Gestational age of rash and risk of Zika related adverse outcomes in the Zika positive group of the MERG Pregnancy Cohort in Pernambuco, Brazil (2015–
2017).
Trimester of rash Number of childrenb Number of cases (%) 95%-CI Relative risk (95%-CI) p-value
Microcephaly 278 7
First 38 1 (1.8) 0.2–10.0 Reference -
Second 86 3 (2.2) 0.7–6.6 1.33 (0.14–36.1) 1.000
Third 154 7 (3.8) 1.8–7.8 1.73 (0.22–13.6) 1.000
Any of the abnormalitiesa 185 45
First 32 8 (25.0) 12.5–43.7 Reference -
Second 63 7 (11.1) 5.3–21.9 0.44 (0.18–1.12) 0.134
Third 90 21 (23.3) 15.6–33.4 0.93 (0.46–1.89) 0.814
aTotal number of children evaluated for at least one of the following: microcephaly, CNS imaging abnormalities, Neurologic Abnormalities, Ophthalmologic
abnormalities.
bThe denominator varies according to the missing values for each outcome.
https://doi.org/10.1371/journal.pntd.0009216.t004
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one of the abnormalities compatible with CZS was around 20%. However, the intersection
between these different abnormalities (microcephaly, imaging, neurologic and ophthalmo-
logic) did not exceed 1%.
Table 5. Absolute risk of Zika related adverse outcomes in the MERG Pregnancy Cohort in Pernambuco, Brazil (2015–2017).







Any of the outcomes
Microcephaly and/or CNS imaging abnormalities and/or Neurologic Abnormalities and/or
Ophthalmologic Abnormalities
At first evaluation
Positive 21/99 21.2 14.1–30.5
Positive + Flavivirus + inconclusive 26/119 21.8 15.2–30.3
At any time
Positive 28/99 28.3 20.2–38.1
Positive + Flavivirus + inconclusive 37/119 31.1 23.3–40.1
Combined outcomes
Microcephaly and CNS imaging abnormalities and Neurologic Abnormalities
At first evaluation
Positivea 1/121 0.8 0.1–5.8
Positive + Flavivirus + inconclusive 1/141 0.7 0.1–5.0
At any time
Positivea 2/121 1.6 0.4–6.5
Positive + Flavivirus + inconclusive 2/141 1.4 0.3–5.6
Microcephaly and Neurologic Abnormalities and Ophthalmologic Abnormalities
At first evaluation
Positive 0/180 - -
Positive + Flavivirusb + inconclusive 1/207 0.5 0.1–3.4
At any time
Positive 0/180 - -
Positive + Flavivirusb + inconclusive 1/207 0.5 0.1–3.4
CNS imaging abnormalities and Neurologic Abnormalities
At first evaluation
Positivec 1/120 0.8 0.1–5.8
Positive + Flavivirus + inconclusive 1/140 0.7 0.1–5.0
At any time
Positivec 1/120 0.8 0.1–5.8
Positive + Flavivirus + inconclusive 1/140 0.7 0.1–5.0
Neurologic Abnormalities and Ophthalmologic Abnormalities
At first evaluation
Positive 1/180 0.5 0.1–3.9
Positive + Flavivirus + inconclusive 3/207 1.4 0.5–4.4
At any time
Positive 3/180 1.7 0.5–5.1
Positive + Flavivirus + inconclusive 5/207 2.4 1.0–5,7
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The frequency of microcephaly is consistent with the results of other studies [6–11]. The
frequency of at least one type of alteration compatible with prenatal exposure to ZIKV infec-
tion in our study lies between the 6% and 46% found by Hoen et al. [7] and Brasil et al. [6],
respectively. However the comparability between studies is limited by the different clinical and
laboratory criteria adopted to define exposure [6,11,27], the limitation of the diagnostic tests to
detect ZIKV infection [18] and by the lack of standardisation to define and assess the outcomes
[6–13]. Investigation of children in the different studies was similar in terms of microcephaly
and imaging, but differed with other outcomes.
Our results suggest that there is not a single presentation of microcephaly, occurring with
or without imaging abnormalities and with the presence, or not, of neurological, and ophthal-
mologic alterations. In Brasil’s cohort the four children with microcephaly had imaging abnor-
malities, half of them had disproportionate microcephaly [6]. However microcephaly without
imaging abnormalities was also described in the French Territories [7], in the U.S. territories
and freely associated states [10] and in the continental US and Hawaii [11]. The finding of
microcephaly in a child born to a mother with no laboratory evidence of ZIKV infection may
be due to false negative result, considering the limitations of the diagnostic tests available [18],
and the fact that it occurred during the microcephaly epidemic by Zika [1]. However, another
congenital infection cannot be excluded as this mother had rash during pregnancy and was
not tested for TORCH. Microcephaly has several causes and is a rare event [28]. The annual
mean of occurrence of cases in the state of Pernambuco in the period before the epidemic was
9 [1,29]. We did not investigate genetic and metabolic disorders and they cannot be discarded
but are not likely to have occurred.
In our study the imaging abnormalities potentially associated with ZIKV infection were
mainly calcifications and ventriculomegaly. A wider variation of abnormalities, particularly in
children with microcephaly, has been registered [30] but calcifications and ventriculomegaly
were among the most frequent. Intracranial calcifications may occur in other congenital infec-
tions like herpes simplex virus, cytomegalovirus and toxoplasmosis and excluding other aetiol-
ogies based on specific mother testing is not without problem.
The risk of neurologic alterations among children born to women with laboratory evidence
of ZIKV infection during pregnancy was of 5% (CI-95%: 2.7–9.1%) occurring either isolated
or in the presence of other type of alterations. The frequency was much lower than that of 26%
described by Brasil et al. [6]. One possible explanation for this difference would be that in the
study of Brasil et al. [6] children were evaluated at birth and, in our study, they were evaluated
later; it is possible that some of these neurologic abnormalities described in the former study
were transient.
We found a risk of ophthalmologic alterations of 6.3% (CI-95%: 3.1%-9.5%), very similar to
the 6% of the cohort of Rio de Janeiro [6], the only other cohort which provides this informa-
tion. The ocular abnormalities we found had been described previously, notably in children
with microcephaly [31] but also in children without microcephaly [32].
The risk of dysphagia among children born to women with laboratory evidence of ZIKV
infection during pregnancy was around 2%, found in children with or without other alter-
ations. Hearing loss and dysphagia associated with congenital virus infection has been previ-
ously described, but only in children with microcephaly [33,34].
When we compared the frequency of abnormalities at birth or first evaluation with those
that were observed at any time during the follow-up, we found that there was an increase only
for the neurological abnormalities. It is not surprising as ophthalmologic abnormalities and
dysphagia were already present at the age when the children were evaluated for the first time
(median age of 4.65 months (IQR: 2.9–13.4)). However, some neurological abnormalities can
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be more easily identified or may appear as children get older; for example, epilepsy, motor
abnormalities and maturational milestones may not be detectable until later ages.
Overall, we found no statistically significant differences in the risks of adverse outcomes in
children born to mothers with non-negative or negative ZIKV test results. However, these
results need to be interpreted with caution as the latter group may not be truly negative for
ZIKV infections. As this is a cohort of PW notified with rash, all participants had symptoms
compatible with ZIKV infection during an active epidemic. In fact, in addition to rash, in the
negative group, almost 80% of the mothers reported fever, arthralgia or fatigue and more than
60% reported myalgia, among other symptoms. Limitations of the accuracy of the diagnostic
tests for ZIKV and the narrow time window in which the molecular tests remain positive [18]
also increase the uncertainty in excluding this diagnosis [18]. Another point to be considered
is that, due to financial and operational constrains, we prioritized the evaluation of children
born to mothers who had laboratory evidence of ZIKV infection during pregnancy. Therefore,
the number of children born to mothers who tested negative is small, especially in relation to
neurologic and ophthalmologic assessments, and therefore the power to detect differences in
the risk of abnormalities between children born to mothers of this group and those born to
non-negative mothers is low. In summary, false negative results and lack of power may underly
the lack of association between adverse outcomes and positive ZIKV test results.
The definition of CZS is still being built and the clinical features of the less severe cases are
not well known. Our results suggest that abnormalities occur more frequently isolated than in
combination. The frequency of any adverse outcome could be as high as one in five children
whose mother was infected during pregnancy but the frequency of the concomitant presenta-
tion of microcephaly, imaging, neurologic and ophthalmologic abnormalities was very low.
Even for the children with microcephaly, there was a degree of variation, including children
with no other abnormality detected. The reason for differences in the presentation needs to be
further explored. It would be expected more severe cases in children born to mothers infected
in the first trimester of pregnancy as observed in some studies [7,8,11] and in other congenital
diseases [35,36]. However, abnormalities were also found in children born to mothers who
were infected later in pregnancy. Another point to learn the full spectrum is that some neuro-
developmental abnormalities, which may be an important component of this Syndrome, will
only be better evaluated later in these children.
As pregnant women were notified because of presence of rash this symptom was reported
in the interview by 98% of them. The characteristics of the rash did not differ between those
who had or not laboratory evidence of ZIKV infection and, in general, it was not possible to
distinguish Zika infection just by clinical characteristics. The proportion of laboratory evi-
dence of DENV and CHIKV infection among those who had no laboratory evidence of Zika
was small.
Five infant deaths occurred after delivery, three of which, including two children with
Down Syndrome, in children with severe cardiac malformation which are not likely to be
related with ZIKV infection. For the other foetal or infant deaths it is not possible to evaluate
whether ZIKV infection was a contributing factor.
Overall, the cohort had a low socioeconomic status, with approximately two-thirds of par-
ticipants belonging to the lower social classes and only a small proportion of the mothers hav-
ing higher education. An ecological study carried out by MERG showed that there was a
strong association between a higher prevalence of microcephaly and poor living conditions in
the Metropolitan Region of Recife [37]. In fact, this area is characterized by high social inequal-
ity, and the pattern of distribution of several infectious diseases reflects the uneven social con-
ditions [38,39].
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The frequency of TORCH (Toxoplasmosis, Rubella, Cytomegalovirus and Parvovirus)
infections among the pregnant women was low, but at least one-third of those tested for Chi-
kungunya were positive. We note that Zika and Chikungunya viruses were co-circulating in
this area in the same period and the neurological manifestations of the dual infection in the
adult population has been recently described [40]. We cannot rule out that CHIKV may be
playing a role in some of the outcomes we found.
This study has some strengths and limitations. The partnership with health authorities by
using the notification system in the recruitment of pregnant women with rash in the context
of the public health emergency reduced the risk of selection bias. There was a higher health-
seeking behaviour increasing the sensitivity in detecting women with rash. The use of different
laboratory technics and sequenced tests allowed to compare hierarchical groups of evidence of
ZIKV infection in a sensitive analysis. The use of longitudinal molecular and serologic testing
enhanced diagnostic sensitivity for defining cases of ZIKV infection among pregnant women
presenting with rash and allowed us to detect a larger number of infected women. Another
strength was the standardized and deep investigation of infant outcomes, performed by experi-
enced specialists.
The children were not evaluated at birth and the time elapsed until the first evaluation var-
ied. Early transient symptoms may not have been detected, but the adverse outcomes which
were diagnosed are likely to be persistent. Furthermore, as impairments may manifest at a
later age, some abnormalities were only detected because of the delayed evaluation. Later man-
ifestations point to the need to follow these children for a longer period.
Asymptomatic pregnant women were not included and it is possible that risk estimates for
children born to asymptomatic pregnant women could differ but there is no evidence to date
that it occurs [8,41].
Misclassification in relation to exposure may have happened due to the limitations of the
laboratory tests, the short duration of viremia and the overlapping of the clinical features with
other arbovirus infections and TORCHs. However, there was no marked difference in the fre-
quency of adverse outcomes between the groups with different levels of evidence. Errors of
classification may also have occurred in the unexposed group because they were symptomatic
and therefore could have another infection.
Not all children were evaluated for all outcomes. However, as the children were not selected
to the comprehensive evaluation for any particular reason, it may have decreased the sample
size but it is not likely to have introduced any selection bias.
We may not exclude that there may have been some abnormalities noted in the infants
born to mothers with laboratory evidence which have an aetiology unrelated to ZIKV. Other
studies with an adequate control group of unexposed women would allow the estimation of
the attributable risk.
Conclusions and recommendations
The frequency of microcephaly in our results is consistent with previous studies. In addition,
as the children were evaluated at a later age and repeatedly by different groups of specialists
our findings provide new insight into the absolute risk of more specific abnormalities, espe-
cially those more likely to be persistent, and suggest that isolated manifestations occur more
frequently than in combination. Due to the rare nature of some outcomes and the possibility
of later manifestations of some components of the syndrome, large scale individual participant
data meta-analysis to explore subgroups and the long term evaluation of children are impera-
tive to identify the full spectrum and to plan actions to reduce the damages of the Congenital
Zika Syndrome. For the children with microcephaly, we recommend a comprehensive clinical
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examination by the paediatrician to identify other adverse outcomes/complications and the
early initiation of neuropsychomotor stimulation. For the other exposed but symptomatic or
asymptomatic children, we recommend screening for neurologic and ophthalmologic abnor-
malities and developmental delay.
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Microbiol Infect. 2018; 24(6):646–52. Available from: https://doi.org/10.1016/j.cmi.2017.11.004 PMID:
29133154
14. WHO. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005)
Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal mal-
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